Newton One Investments’s Bristol-Myers Squibb BMY Stock Holding History

Newton One Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,180	Closed	-$68.5K	–	116
2023 Q3	$68.5K	Buy	1,180 +11	+0.9%	+$674	0.04%	60
2023 Q2	$74.8K	Buy	1,169 +9	+0.8%	+$604	0.04%	61
2023 Q1	$80.4K	Hold	1,160	–	–	0.05%	58
2022 Q4	$83.4K	Hold	1,160	–	–	0.05%	57
2022 Q3	$82K	Hold	1,160	–	–	0.06%	54
2022 Q2	$89K	Hold	1,160	–	–	0.07%	54
2022 Q1	$85K	Hold	1,160	–	–	0.06%	59
2021 Q4	$72K	Buy	1,160 +10	+0.9%	+$587	0.05%	60
2021 Q3	$68K	Buy	1,150 +8	+0.7%	+$527	0.05%	60
2021 Q2	$76K	Buy	1,142 +9	+0.8%	+$587	0.06%	58
2021 Q1	$72K	Buy	1,133 +8	+0.7%	+$498	0.06%	43
2020 Q4	$70K	Buy	+1,125	New	+$69.2K	0.07%	41

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Newton One Investments's BMY Position: Q4 2023 in Review

Newton One Investments sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 1,180 shares — an estimated $68.5K sold.

Newton One Investments first reported a position in BMY in Q4 2020 and held it in 12 quarters. The position peaked at $89K in Q2 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Newton One Investments reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Newton One Investments sold 1,180 Bristol-Myers Squibb shares in Q4 2023, an estimated $68.5K.
Newton One Investments first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 12 quarters.
Newton One Investments's Bristol-Myers Squibb position peaked at $89K in Q2 2022.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Newton One Investments's 13F filing for Q4 2023, filed 23 Jan 2024.